38: Safety of Beta Blockers for the Treatment of PHACE Syndrome
Alexandra Finstad(University of Toronto), Cathryn Sibbald(University of Toronto), Elena Pope(University of Toronto), Yuliya Lytvyn(University Health Network)
Cited by 0
Related Papers
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
|American Journal of Physiology-Renal Physiology|2014|173
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
|Endocrine Reviews|2019|171
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
|Diabetologia|2014|162
Uric Acid as a Biomarker and a Therapeutic Target in Diabetes
|Canadian Journal of Diabetes|2015|138